NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹82 Cr | ₹90 Cr | ₹66 Cr | ₹64 Cr | ₹38 Cr |
What is the latest Sundry Debtors ratio of NGL FINECHEM ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹82 Cr |
| Mar2024 | ₹90 Cr |
| Mar2023 | ₹66 Cr |
| Mar2022 | ₹64 Cr |
| Mar2021 | ₹38 Cr |
How is Sundry Debtors of NGL FINECHEM Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹82 Cr | -9.00 | |
| Mar2024 | ₹90 Cr | 36.05 | |
| Mar2023 | ₹66 Cr | 2.96 | |
| Mar2022 | ₹64 Cr | 70.35 | |
| Mar2021 | ₹38 Cr | - | |
Compare Sundry Debtors of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹933.2 Cr | 2.4% | 17.7% | -7.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 2.4% |
17.7% |
-7.4% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses